New Treatments Could Transform Care for Hidradenitis Suppurativa (HS)
A new report predicts that the market for hidradenitis suppurativa (HS) treatments will grow significantly over the next decade, from […]
A new report predicts that the market for hidradenitis suppurativa (HS) treatments will grow significantly over the next decade, from […]
European drug regulators have recommended rejecting Elevidys, a gene therapy for Duchenne muscular dystrophy (DMD), in a setback for its
Astellas and Apellis are competing for market share in the U.S. for their geographic atrophy (GA) treatments, Izervay and Syfovre.
The pharmaceutical industry is highly competitive, which has led to a big increase in healthcare advertising, with spending expected to
Earlier this year, EyePoint Pharmaceuticals faced doubts about its drug-device combo, Duravyu, after it failed in a study for nonproliferative
Here’s a simplified version of the text: There’s a rare heart condition known as transthyretin amyloidosis cardiomyopathy that has caught
In the pharmaceutical world, there’s a big competition to create the best obesity drugs, currently dominated by Novo Nordisk and
Here’s a simplified summary of the regulatory updates for various pharmaceutical products: 1. **Pfizer’s Elrexfio**: Recommended in England for multiple
Thorsten Stafforst recalls being discouraged from pursuing his research. In the early 2010s, scientists were excited about CRISPR, a tool
At a conference in New England, Rohan Simon, an associate director at the UAE’s first contract research organization, discussed the